David F. Barker

8.3k citations

77 papers · 6.5k indexed · 3 hit papers · h-index 33

Molecular Biology top 2%
Cellular and Molecular Neuroscience top 1%
Genetics top 1%
Oncology top 2%
Neurology top 1%

Co-authors: Allan Campbell David H. Ledbetter Yusuke Nakamura Peter vanTuinen R. White J. Milburn Jessup Eric R. Fearon Suzanne J. Baker
Topics: Genomic variations and chromosomal abnormalities (11 papers)Cell Adhesion Molecules Research (10 papers)Hereditary Neurological Disorders (8 papers)
Cited by: Immunology and Allergy Cellular and Molecular Neuroscience Neurology
Journals: Nature Science Cell
Partner nations: United States Canada United Kingdom

In The Last Decade

David F. Barker

76 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas

1989 1.7k citations David H. Ledbetter, David F. Barker et al. profile →
DNA duplication associated with Charcot-Marie-Tooth disease type 1A

1991 1.0k citations David F. Barker et al. profile →
Identification of Mutations in the COL4A5 Collagen Gene in Alport Syndrome

1990 612 citations David F. Barker, Jing Zhou et al. profile →

Peers

Countries citing papers authored by David F. Barker

Since Specialization

Citations

This map shows the geographic impact of David F. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David F. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David F. Barker more than expected).

Fields of papers citing papers by David F. Barker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David F. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David F. Barker. The network helps show where David F. Barker may publish in the future.

Co-authorship network of co-authors of David F. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of David F. Barker. A scholar is included among the top collaborators of David F. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David F. Barker. David F. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine 2016 ·Toxicology in Vitro ·Smita Ghare,Hridgandh Donde,Wei-Yang Chen,David F. Barker,(unknown),Craig J. McClain,Shirish Barve,Swati Joshi‐Barve	5
2	Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease 2015 ·Clinical Immunology ·Leila Gobejishvili,Smita Ghare,Rehan Khan,A. Cambon,David F. Barker,Shirish Barve,Craig J. McClain,Daniell B. Hill	12
3	Alport Syndrome � Clinical Phenotypes, Incidence, and Pathology1,2 2015 ·Contributions to nephrology ·Martin C. Gregory,Daniel Terreros,David F. Barker,(unknown),(unknown),Curtis L. Atkin	5
4	S-Adenosylmethionine Decreases Lipopolysaccharide-Induced Phosphodiesterase 4B2 and Attenuates Tumor Necrosis Factor Expression via cAMP/Protein Kinase A Pathway 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Leila Gobejishvili,(unknown),David F. Barker,Smita Ghare,David Henderson,Guy Brock,Irina Kirpich,Swati Joshi‐Barve,Sri Prakash Mokshagundam,Craig J. McClain,Shirish Barve	39
5	Manganese Superoxide Dismutase Expression as a Function of Genotype and Lung Cancer Pathology 2010 ·Cancer Investigation ·Robert C.G. Martin,Yan Li,(unknown),David F. Barker,Mark A. Doll,David W. Hein	10
6	Manganese Superoxide Dismutase Gene Coding Region Polymorphisms Lack Clinical Incidence in General Population 2008 ·DNA and Cell Biology ·Robert C.G. Martin,David F. Barker,Mark A. Doll,Sharon R. Pine,Leah E. Mechanic,Elise D. Bowman,Curtis C. Harris,David W. Hein	3
7	Manganese Superoxide Dismutase V16A Single-Nucleotide Polymorphism in the Mitochondrial Targeting Sequence Is Associated with Reduced Enzymatic Activity in Cryopreserved Human Hepatocytes 2008 ·DNA and Cell Biology ·Robert C.G. Martin,Yan Li,(unknown),Neil S. Jensen,David F. Barker,Mark A. Doll,David W. Hein	32
8	Functional Analysis of the Human N-Acetyltransferase 1 Major Promoter: Quantitation of Tissue Expression and Identification of Critical Sequence Elements 2007 ·Drug Metabolism and Disposition ·Anwar Husain,Xiaoyan Zhang,Mark A. Doll,J. Christopher States,David F. Barker,David W. Hein	38
9	Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth 2003 ·Human Mutation ·Beth K Thielen,David F. Barker,Raoul D. Nelson,Jing Zhou,Stefan M. Kren,Yoav Segal	17
10	Nonmuscle Myosin Heavy Chain IIA Mutations Define a Spectrum of Autosomal Dominant Macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein, and Alport-Like Syndromes 2001 ·The American Journal of Human Genetics ·Karen E. Heath,Ángel Campos‐Barros,Amos Toren,Galit Rozenfeld-Granot,Lena E. Carlsson,Judy Savige,(unknown),Martin C. Gregory,James G. White,David F. Barker,Andreas Greinacher,Charles J. Epstein,Marc Glucksman,John A. Martignetti	205
11	Direct genomic multiplex PCR forBRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis 2000 ·Human Mutation ·David F. Barker	8
12	Expression of mRNA for type IV collagen α1, α5 and α6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome 1998 ·Matrix Biology ·Shigekazu Sasaki,(unknown),Weiwei Fan,(unknown),David F. Barker,(unknown),Curtis L. Atkin,Martin C. Gregory,Jing Zhou,Yoav Segal,Yoshikazu Sado,Y Ninomiya,(unknown),Clifford E. Kashtan	13
13	A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. 1996 ·PubMed ·David F. Barker,Charles J. Pruchno,(unknown),Curtis L. Atkin,Edwin M. Stone,(unknown),Pamela R. Fain,Martin C. Gregory	57
14	The BRCA1 and 1A1.3B Promoters Are Parallel Elements of a Genomic Duplication at 17q21 1996 ·Genomics ·David F. Barker,Xudong Liu,(unknown)	21
15	Fine structure mapping of the human X-linked hypophosphatemic rickets gene locus. 1994 ·The Journal of Clinical Endocrinology & Metabolism ·Michael J. Econs,Peter Rowe,Fiona Francis,David F. Barker,Marcy C. Speer,(unknown),Pamela R. Fain,J. Weissenbach,Andrew Read,(unknown)	17
16	Linkage Analysis and Physical Mapping near the Gene for X-Linked Agammaglobulinemia at Xq22 1993 ·Genomics ·Ornella Parolini,J. Fielding Hejtmancik,R.Cutler Allen,John W. Belmont,(unknown),(unknown),David F. Barker,Mary Ellen Conley	43
17	MRX8: An X‐linked mental retardation condition with linkage to Xq21 1992 ·American Journal of Medical Genetics ·Charles E. Schwartz,Melanie May,Tim H.‐M. Huang,David H. Ledbetter,Gail S. Anderson,David F. Barker,(unknown),Fernando Arena,Roger E. Stevenson	16
18	Two polymorphic TaqI sites at the human NGFR locus (17q12 – 17q22) 1989 ·Nucleic Acids Research ·(unknown),Pamela R. Fain,David F. Barker,Moses V. Chao	1
19	Studies on locus expansion, library representation, and chromosome walking using an efficient method to screen cosmid libraries 1988 ·Gene ·Donald W. Bowden,(unknown),(unknown),Thomas C. Gravius,David F. Barker,Helen Donis-Keller	11
20	Genetic analysis of NF1: Identification of close flanking markers on chromosome 17 1987 ·Genomics ·Pamela R. Fain,David F. Barker,David E. Goldgar,E Wright,K. Nguyen,John C. Carey,(unknown),J. Kivlin,H.F. Willard,Christopher G. Mathew,B A Ponder,Mark H. Skolnick	54

About David F. Barker

David F. Barker is a scholar working on Immunology and Allergy, Genetics and Hematology, having authored 77 papers that have together received 6.5k indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (11 papers), Cell Adhesion Molecules Research (10 papers) and Hereditary Neurological Disorders (8 papers). The work is most often cited by research in Immunology and Allergy (648 citations), Cellular and Molecular Neuroscience (1.5k citations) and Neurology (535 citations). David F. Barker has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Allan Campbell, David H. Ledbetter, Yusuke Nakamura, Peter vanTuinen, R. White, J. Milburn Jessup, Eric R. Fearon, Suzanne J. Baker, Janice Nigro and Stanley R. Hamilton. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact